Rank
132
Eli Lilly
Gerald Abel—Bass Photo Co.
- Previous Rank141
- Revenues ($M)21222
- Revenue Percent Change6.3
- Profits ($M)2737.6
- Profits Percent Change13.7
- Assets ($M)38806
- Employees41975
- Market Value — as of March 31, 2017 ($M)92803
The pharmaceutical giant manufactures drugs for humans as well as for livestock and poultry.
Company Info
| CEO | David A. Ricks |
| CEO Title | President, Chief Executive Officer & Director |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| HQ Location | Indianapolis, IN |
| Website | www.lilly.com |
| Years on Fortune 500 List | 23 |
| Employees | 41,975 |
Key Financials (Last Fiscal Year)
| Revenues ($M) | $21,222 |
| Profits ($M) | $2,737.6 |
| Assets ($M) | $38,806 |
| Total Stockholder Equity ($M) | $14,008 |
| Market Value — as of March 31, 2017 ($M) | $92,803 |
Profit Ratios
| Profit as % of Revenues | 12.9% |
| Profits as % of Assets | 7.1% |
| Profits as % of Stockholder Equity | 19.5% |
Earnings Per Share (Last Fiscal Year)
| Earnings Per Share ($) | 258 |
| EPS % Change (from 2015) | 14.2% |
| EPS % Change (5 year annual rate) | -7.9% |
| EPS % Change (10 year annual rate) | 0.5% |
Total Return
| Total Return to Investors (2016) | -10.2% |
| Total Return to Investors (5 year, annualized) | 15.9% |
| Total Return to Investors (10 year, annualized) | 7.8% |